168 related articles for article (PubMed ID: 27461550)
1. The societal cost of Huntington's disease: are we underestimating the burden?
Jones C; Busse M; Quinn L; Dawes H; Drew C; Kelson M; Hood K; Rosser A; Edwards RT
Eur J Neurol; 2016 Oct; 23(10):1588-90. PubMed ID: 27461550
[TBL] [Abstract][Full Text] [Related]
2. Economic burden of Huntington's disease in Peru.
Silva-Paredes G; Urbanos-Garrido RM; Inca-Martinez M; Rabinowitz D; Cornejo-Olivas MR
BMC Health Serv Res; 2019 Dec; 19(1):1017. PubMed ID: 31888613
[TBL] [Abstract][Full Text] [Related]
3. Economic burden of Huntington disease in Europe and the USA: Results from the Huntington's Disease Burden of Illness study.
Rodríguez-Santana I; Mestre T; Squitieri F; Willock R; Arnesen A; Clarke A; D'Alessio B; Fisher A; Fuller R; Hamilton JL; Hubberstey H; Stanley C; Vetter L; Winkelmann M; Doherty M; Wu Y; Finnegan A; Frank S
Eur J Neurol; 2023 Apr; 30(4):1109-1117. PubMed ID: 36421029
[TBL] [Abstract][Full Text] [Related]
4. Health state utility values (QALY weights) for Huntington's disease: an analysis of data from the European Huntington's Disease Network (EHDN).
Hawton A; Green C; Goodwin E; Harrower T
Eur J Health Econ; 2019 Dec; 20(9):1335-1347. PubMed ID: 31410669
[TBL] [Abstract][Full Text] [Related]
5. Health related quality of life, service utilization and costs for patients with Huntington's disease in Norway.
van Walsem MR; Frich JC; Gómez Castañeda M; Howe EI; Pihlstrøm L; Andelic N; Aas E
BMC Health Serv Res; 2022 Dec; 22(1):1527. PubMed ID: 36517848
[TBL] [Abstract][Full Text] [Related]
6. Economic Burden of Huntington's Disease in China: Results from a National-Wide Cross-Sectional Study.
Chen S; Zhang H; Yu J; Cao X; Zhang S; Dong D
Neuroepidemiology; 2024; 58(1):31-36. PubMed ID: 38142687
[TBL] [Abstract][Full Text] [Related]
7. Healthcare utilization and monetary costs associated with agitation in UK care home residents with advanced dementia: a prospective cohort study.
Buylova Gola A; Morris S; Candy B; Davis S; King M; Kupeli N; Leavey G; Moore K; Nazareth I; Omar R; Vickerstaff V; Jones L; Sampson EL
Int Psychogeriatr; 2020 Mar; 32(3):359-370. PubMed ID: 31948510
[TBL] [Abstract][Full Text] [Related]
8. The direct medical costs of Huntington's disease by stage. A retrospective commercial and Medicaid claims data analysis.
Divino V; Dekoven M; Warner JH; Giuliano J; Anderson KE; Langbehn D; Lee WC
J Med Econ; 2013 Aug; 16(8):1043-50. PubMed ID: 23789925
[TBL] [Abstract][Full Text] [Related]
9. Estimated societal costs of stroke in the UK based on a discrete event simulation.
Patel A; Berdunov V; Quayyum Z; King D; Knapp M; Wittenberg R
Age Ageing; 2020 Feb; 49(2):270-276. PubMed ID: 31846500
[TBL] [Abstract][Full Text] [Related]
10. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.
Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():19-29. PubMed ID: 27038625
[TBL] [Abstract][Full Text] [Related]
11. Healthcare utilization and cost burden of Huntington's disease among Medicare beneficiaries in the United States.
Exuzides A; Reddy SR; Chang E; Ta JT; Patel AM; Paydar C; Yohrling GJ
J Med Econ; 2021; 24(1):1327-1336. PubMed ID: 34730477
[TBL] [Abstract][Full Text] [Related]
12. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Nicod E; Serrano-Aguilar P;
BMC Health Serv Res; 2015 Sep; 15():428. PubMed ID: 26416027
[TBL] [Abstract][Full Text] [Related]
13. Disease Burden of Huntington's Disease (HD) on People Living with HD and Care Partners in Canada.
Shaw E; Mayer M; Ekwaru P; McMullen S; Graves E; Wu JW; Budd N; Maturi B; Cowling T; Mestre TA
J Huntingtons Dis; 2022; 11(2):179-193. PubMed ID: 35342095
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and economic burden of Huntington's disease: a Canadian provincial public health system perspective.
Shaw E; Mayer M; Ekwaru P; McMullen S; Graves E; Wu JW; Budd N; Maturi B; Cowling T; Mestre TA
J Med Econ; 2022; 25(1):212-219. PubMed ID: 35073826
[TBL] [Abstract][Full Text] [Related]
15. Survey of the Huntington's Disease Patient and Caregiver Community Reveals Most Impactful Symptoms and Treatment Needs.
Simpson JA; Lovecky D; Kogan J; Vetter LA; Yohrling GJ
J Huntingtons Dis; 2016 Dec; 5(4):395-403. PubMed ID: 27983566
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records.
Evans SJ; Douglas I; Rawlins MD; Wexler NS; Tabrizi SJ; Smeeth L
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1156-60. PubMed ID: 23482661
[TBL] [Abstract][Full Text] [Related]
17. Healthcare resource utilization and costs in individuals with Huntington's disease by disease stage in a US population.
Exuzides A; To TM; Abbass IM; Ta JT; Patel AM; Surinach A; Fuller RLM; Luo J
J Med Econ; 2022; 25(1):722-729. PubMed ID: 35608039
[TBL] [Abstract][Full Text] [Related]
18. Social/economic costs and quality of life in patients with haemophilia in Europe.
Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():53-65. PubMed ID: 27048374
[TBL] [Abstract][Full Text] [Related]
19. An Overview of Specialist Services for Huntington's Disease in the United Kingdom.
Willock R; Rickards H; Rosser AE; Haw A; Stanley C; Hossain P; Rodríguez-Santana I; Doherty M; Blair R; Kane W
J Huntingtons Dis; 2023; 12(4):363-370. PubMed ID: 38108355
[TBL] [Abstract][Full Text] [Related]
20. Comorbidities and clinical outcomes in adult- and juvenile-onset Huntington's disease: a study of linked Swedish National Registries (2002-2019).
Furby H; Moore S; Nordstroem AL; Houghton R; Lambrelli D; Graham S; Svenningsson P; Petersén Å
J Neurol; 2023 Feb; 270(2):864-876. PubMed ID: 36253622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
